It is generally agreed that the addition of corticotropin and the glucocorticoids to the therapy of the nephrotic syndrome has brought about a significant reduction in the morbidity and mortality of this disorder, although it is still too soon to be certain of the ultimate survival rate.`' While many aspects of treatment with these medications have become relatively standardized, opinions vary as to the optimum duration of steroid treatment, and whether the tendency to prolong steroid administration is justified by an improvement in prognosis. When first introduced, cortisone and corticotropin were given in 5 to 16 day courses solely to induce diuresis.`8 Subsequently Lange, et al.' noted that the frequency of exacerbations could be appreciably reduced if the initial treatment was followed by up to eight weeks of intermittent therapy (three consecutive days each week). Cooke'0 proposed that the duration of treatment be as long as 24 weeks, and Lange, et al.' in 1958 further extended the time to 18 months. Others have felt, however, that such prolonged administration is neither necessary nor advisable."
At this institution in recent years a policy had evolved of treating children who had the nephrotic syndrome with high doses of glucocorticoids for rather long periods of time. This was done because of a growing impression that the long-term results of such therapy were superior to those of comparatively limited treatment schedules, and vastly superior to those obtained before the availability of steroids.
It was felt that a review of our experience was indicated not only to confirm or deny the above impression but also to obtain a clearer picture of the modifications which modern therapy have imposed upon the natural history of the disorder since it was reviewed at this institution in 1949.'
Glucocorticoid therapy in nephrotic syndrome I GRYBOSKI, BRANDT Such a retrospective study possesses the usual deficiencies expected when reviewing a large group of patients seen over a number of years by different physicians whose policies changed as experience was accumulated. On the III. Clinically well with severe proteinuria (+++ or ++++). IV. Nephrotic syndrome, active. V. Deceased. other hand, it may provide a valuable guide in approaching similar problems in the future.
The present study indicates that glucocorticoid therapy has favorably affected the prognosis in the nephrotic syndrome but that the results obtained here with long-term administration do not appear to differ from those obtained at other centers employing shorter treatment schedules.
CASE MATERIAL
The 71 patients reviewed in this series developed the nephrotic syndrome when they were under 16 years of age; they were both ward and private patients in the Yale-New Haven Medical Center between September 1950 and September 1960, and numbered 21 females (30%) and 50 males (70%). Among them were 65 Caucasian, 3 Negro and 3 Puerto Rican children. The age distribution at the time of onset is shown in Figure 1 . The youngest patient was 10 months and the oldest 15¼2 years. Illness occurred in the majority after the age of one and before the age of six. The highest incidence of the disorder was during the third year of life. Allergy was present in 17 (24%) and diabetes developed in one patient. In three families (4%o) there were two siblings with nephrosis. In two of the families, only one sibling was included in this series; in one a brother had previously recovered and in the other a brother had died of the disease prior to 1950. Renal disease other than nephrosis (nephritis, pyelonephritis, nephrolithiasis or renal carcinoma) was present in the families of 25 patients (32%). Diabetes was present in 10 families (14%o) and allergy in 22 families (31%).
Two-thirds of the cases developed in the spring and fall (35% and 31% respectively), while the remainder was divided equally between summer and winter.
The onset of the condition in 40 patients (56%) was preceded or accompanied by another disorder, usually infectious in nature (see Table 1 ). A 3 cm. reaction to an insect bite was noted five days prior to the onset of nephrosis in one patient. In another, paint ingestion preceded the onset of nephrosis and lead encephalopathy by one month.
The following laboratory determinations were performed: blood hematocrit, hemoglobin and red and white cell and differential counts; intracutaneous PPD using 0.00001 mg.; urinalysis; intravenous pyelography; L.E. cell test; urine culture; blood urea nitrogen or nonprotein nitrogen; and serum albumin, globulin, cholesterol, sodium, potassium, chloride and total carbon dioxide. The usual criteria used in making the diagnosis of nephrotic syndrome are edema, proteinuria, hypoalbuminemia and hypercholesterolemia. As noted in Table 2 , 2 children had no edema, 3 had serum albumin values greater than 3 g/100 ml and 6 had serum cholesterol values less than 280 mg/100 ml. All eventually demonstrated the complete syndrome, however, except for two patients who responded rapidly to therapy and have remained well since.
At least one manifestation of nephritis was present in 22 (31%o) patients at onset. Hypertension, defined as an arterial blood pressure greater than 130/90 mm. Hg, was present in nine patients (12%o). Azotemia, a blood urea nitrogen above 20 mg/100 ml or nonprotein nitrogen above 40 mg/100 ml, was present in 18 (25%o). Hematuria, the presence of three or more red blood cells per high power field in the centrifuged sediment of a casual specimen, was noted in 16 patients (23%o). Hypertension and hematuria were present in one of these patients, azotemia and hematuria in one, and all three signs of nephritis were present in three cases. If more than one of these manifestations persisted after diuresis had been achieved, the additional diagnosis of chronic nephritis was made and glucocorticoid therapy was terminated. A relapse was considered to have taken place if the patient developed a moderate or heavy proteinuria which persisted more than about five days or was initially accompanied by an elevation of the erythrocyte sedimentation rate and a decrease in the serum albumin concentration.
MANAGEMENT
In general, the children were allowed to determine their own activity and no dietary restrictions were imposed unless edema was pronounced. At such times no salt was added during the preparation of food. Abdominocentesis and thoracentesis were done only when the degree of discomfort merited such treatment. In certain cases where edema was refractory to steroid therapy (up to 60 mg. of prednisone per day) spironolactone (Aldactone®), chlorothiazide (Diuril®) and supplementary potassium chloride were also given. Confinement to the hospital was minimized.
At home the patients' urines were tested by the parents with sulfosalicylic acid three times weekly. During acute illness the tests were done daily.
Antibiotics. Antibiotics were given along with steroid therapy. Prior to 1951, these were used only for the treatment of specific infection. Since that time oral penicillin (200,000 to 600,000 units per day) or, more commonly, one of the tetracyclines (15 to 25 mg. per kilogram per day) has Glucocorticoid therapy in nephrotic syndrome GRYBOSKI, BRANDT been employed for prophylaxis. This has been given until one year after the termination of steroid therapy.
Glucocorticoid therapy. In the majority of cases treatment was begun with ACTH (corticotropin) and then continued with a glucocorticoid. The latter was initially given daily in four divided doses (continuous therapy), and after three to six months was given only on three or four consecutive days each week or each two weeks (intermittent therapy). This was maintained until the urine had been protein-free for about three years.
Specific therapeutic regimens will be outlined in the next section.
RESULTS
The status of the group at the end of the 10 year period is indicated in Figure 2 . Twelve (18%f) were in complete remission 2 months to 9 years following the completion of therapy. Forty-three (60%o) were in complete remission but were still receiving some form of glucocorticoid therapy. Three (4% ) were clinically well with mild proteinuria, one (1 %o ) was clinically well with marked proteinuria, two (3%o) had the nephrotic syndrome and 10 (14%o) had expired. One of these children (R. Br., Table 3 ) died in 1958 in the ninth year of his disease, while receiving continuous prednisone therapy for his eighth recurrence.
The remaining seven children were free of proteinuria and in complete remission. In five of these patients steroid therapy had been discontinued from 2 to 9 years. The other two children were still receiving treatment. C. In 22 of the patients the initial course of ACTH was immediately followed by intermittent therapy with 200 to 400 mg. of cortisone or its equivalent of hydrocortisone for three consecutive days each week for a period of 1 to 6 years. Three patients died in uremia during or after this therapeutic program: one (G.W.) in 1957, two years after the steroid therapy had been discontinued because of severe hypertension and azotemia; and two (R.Ba., B.Mc.) in 1954 and 1955, while still receiving steroid therapy.
One patient treated from 1950 to 1954 developed diabetes while receiving intermittent therapy eight months after the onset of nephrosis and seven months after beginning therapy; he is now clinically well with persistent mild proteinuria.
Another, who developed the disorder in 1954, became refractory to therapy even though ACTH, cortisone and prednisone were variously employed. Although at the conclusion of the study he continued to manifest the nephrotic syndrome while still receiving prednisone, he was without clinical evidence of nephritis.
Seventeen patients were in complete remission, and steroid had been discontinued in five of these from 2 months to 4 years. D. The initial course of ACTH was followed by continuous treatment with a glucocorticoid in 29 patients. 1. Twenty-four received 30 to 60 mg. per day of prednisone which was reduced over a 2 to 8 month period to 10 to 25 mg. per day; they then were given Glucocorticoid therapy in nephrotic syndrome I GRYBOSKI, BRANDT this reduced dosage for three or four consecutive days each week or each two weeks (intermittent therapy) for 1Y2 to 6 years.
One child (L.A.) died in 1955 while on continuous prednisone during the third week of therapy.
Another patient fulfilled the criteria for the diagnosis of chronic nephritis in 1958 during the seventh month of continuous therapy, and therapy was therefore discontinued; she continues to have mild proteinuria.
Twenty-two patients were in complete remission, but all were receiving steroids at the conclusion of the study period. 2. Four received 100 to 400 mg. of cortisone per day for 3 months to 2 years and were then maintained on intermittent therapy at the same dosage three consecutive days each week for an additional 2 to 6 years. All in this group were in complete remission at the end of the study period, and all but one were still receiving steroid. 3. One patient received prednisolone daily starting at 10 mg. and increasing to 30 mg. over four months. This was then discontinued because of persistent, severe hypertension; the patient (C.Z.) died five months later normotensive, but in uremia and with E. Coli sepsis.
II. Nine patients began treatment with prednisone, 30 to 60 mg. per day, between 1956 and 1960. After 10 to 31 days the dose was reduced gradually over a 1 to 4 month period, but continuous therapy was maintained for 3 to 9 months. Two patients (K.F., D.T.) died during the initial, continuous therapy four and five months, respectively, after the onset of treatment.
A third patient (J.M.) died in the second year of his disease. He had received an additional course of continuous prednisone therapy for one month for treatment of a relapse, but this was discontinued one month prior to death because of lethargy, hypertension and azotemia. Following one week of therapy with 125 mg. daily of chlorothiazide, he expired with hypokalemia.
One patient had mild proteinuria after three months of continuous therapy. Two months after the end of the study period, while still receiving continuous therapy, she became free of proteinuria.
The single patient who was clinically well but had marked proteinuria persisting after nine months of continuous therapy, was a 15 year old Caucasian female whose renal tissue, obtained by percutaneous needle biopsy at that time, demonstrated focal membranous glomerulonephritis. Otherwise, she had no clinical manifestations of chronic nephritis and L.E. cell tests and studies for antinuclear globulins were negative. Glucocorticoid therapy was then discontinued.
A 14 year old Negro female, who continued to manifest the nephrotic syndrome after eight months of continuous therapy, was also without clinical evidence of nephritis. Steroid therapy was discontinued after percutaneous renal biopsy revealed generalized hyalinization and contraction of the glomeruli.
The remaining three patients were in complete remission while still receiving steroid therapy. III. In one patient, 200 mg. of cortisone for 14 days was used initially and followed by intermittent cortisone therapy (three consecutive days each week of the same daily dose) for 3Y2 years. The patient was in complete remission three years after discontinuation of steroid.
IV. One patient initially was given triamcinolone. Following a three week course of 32 mg. per day, therapy was continued at a reduced daily dose (8 mg.) for four months. This was followed up to the end of the study period by intermittent prednisone at a dose of 20 mg. for four consecutive days each week for two years. He was in complete remission at that time. ** The patient was receiving 20 mg. daily of prednisone. His serum NPN was 65 mg/100 ml, and his blood pressure 180/120 mm Hg the day before he died. Two weeks previously his NPN was 40 mg/100 ml, and his blood pressure 140/100 mm Hg.
Ten children had failed to survive to the end of the study period (Table  3) . Six of them were male (5 Caucasian and 1 Puerto Rican) and four were female (3 Caucasian and 1 Puerto Rican). The duration of the nephrotic syndrome was 2X2 months to 9 years. Five children died within five months of onset; autopsy or renal biopsy revealed normal glomeruli or thickening of the basement membrane in three, and proliferative glomerulonephritis with occasional hyalinized glomeruli in two. The three patients who manifested marked hematuria, hypertension and azotemia 266 Volume 35, December 1962 Glucocorticoid therapy in nephrotic syndrome I GRYBOSKI, BRANDT at onset were in this group. Two of these had histological evidence of nephritis: one (P.R.) died during initial ACTH therapy and the other (L.A.) during continuous therapy. The third (D.T.) died during the fourth month of continuous therapy. The other five died more than one year after the onset. Autopsy performed on three of them revealed proliferative glomerulonephritis in one and membranous glomerulonephritis with a predominance of hyalinized and contracted glomeruli in the others. Autopsy Figure 1 .
was not performed on two patients. One of these fulfilled the criteria for chronic nephritis three months prior to death and the second did so 24 hours prior to death. There was no statistically significant difference in mortality rate between patients treated prior to and after the disorder had been present for three inonths ( Table 4 ). The number of cases in the second category, however, would appear to be too small to confirm any conclusion about the effect of delay in instituting therapy upon the prognosis of the disorder.
The majority of patients in complete remission at the end of the survey responded within the first three weeks of treatment. Mortality and morbidity increased as the time required to respond extended beyond this period (Table 4 ). In the 3-35 week category 5, 9, 11 and 20 weeks were required for the four patients who achieved Class I, and 7 weeks for the one who achieved Class II. In the greater than 35 week category, 16 and 18 months of therapy were given to the two who achieved Class I and 24 months for the one in Class II.
No differences have been noted in the response to ACTH, cortisone or prednisone. The apparently large proportion of deaths in the exclusively prednisone-treated group was not statistically significant (p > .05).
RELAPSES
Twenty-four children had no relapses after demonstrating a rapid and complete response to glucocorticoid therapy. Nine patients had not responded to therapy and five of these had expired by the end of the study period.
Thirty-eight patients had a total of 102 relapses. Although this averaged 2.7 per relapsing patient, 12 had only one while 17 each had more than three. One patient had 13. Fourteen children had 26 relapses during continuous therapy. Half did so while receiving daily 20 mg. or less of prednisone or 100 mg. or less of cortisone; they had remissions within two weeks of increasing the steroid dose. The other 7 experienced relapses while receiving more than 20 mg. of prednisone per day; at the end of the study period only 2 were in complete remission, 1 had chronic nephritis, .1 had the nephrotic syndrome, and 3 were dead.
Twenty-five children had 54 relapses while receiving intermittent therapy; all but one of them responded to another course of therapy; one patient died of undetermined causes while on treatment. No correlation could be made between the age or steroid dose at the time of relapse and the time required for the urine to become protein-free.
Fourteen children had 22 relapses from 2 weeks to 8 years after completion of steroid therapy. Another course of therapy brought about a remission within two weeks in all instances but one, in which remission did not take place until after two months of therapy.
Interestingly, five of the six children who were Class I and who required more than 3 weeks of therapy to bring about the initial complete remission (Table 4) , had from one to five relapses; all cleared after less than 8 weeks of treatment, usually after less than 4 weeks.
Relapses were associated with a variety of events. Immunizations with diphtheria-pertussis-tetanus, poliomyelitis vaccine and gamma globulin were followed by relapse in 2 patients who had completed therapy and in 3 patients free of proteinuria while on intermittent therapy. One child suffered relapses twice when the steroid-free interval of his intermittent therapy schedule was extended beyond four consecutive days of the week. Two relapses were precipitated in another child when prednisone was sharply decreased to 5 mg. daily following exposures to varicella. Sunburn and bee sting were thought to be responsible factors in two patients. Fourteen patients had 39 exacerbations which were preceded by upper respiratory infection and three had exacerbations preceded by viral enteritis; all responded to continuous therapy, the majority within two weeks. No antecedent factor could be determined for the remaining 49 relapses.
There have been 14 instances of transient proteinuria lasting up to five days and associated with upper respiratory infections. These subsided without alteration of therapy and were not included in the above data.
COMPLICATIONS OF THERAPY
Several patients demonstrated complications of continuous therapy. One developed duodenal ulcer during the fourth month of continuous prednisone therapy, five months prior to death from hypokalemia and uremia, and one died during initial ACTH therapy and had multiple duodenal ulcerations at autopsy. Guaiac-positive stools were noted in three after three weeks of continuous prednisone therapy without radiologic evidence of ulceration in the gastro-intestinal tract. In one of the three the melena subsided spontaneously. The other two responded quickly to demulcent therapy and discontinuation of steroids. Pancreatitis was found at autopsy in the one patient who died during the twelfth day of initial ACTH therapy.
There were no serious intercurrent infections with the exception of the three cases noted in Table 3 Some degree of hyperglucocorticism developed in all patients during initial and continuous therapy, but subsided as the dose of steroid was decreased. Obesity, voracious appetite and marked lability of mood were fairly characteristic. Hypertension developed during the course of therapy in 24 patients. In six it was severe, and five were treated with pentolinium or reserpine. It subsided when steroid was decreased in all cases except C. Z. and A. W. (Table 3) , who died (still hypertensive) 6 and 23 months, respectively, after being taken off therapy. Osteoporosis was noted in X-rays taken of children on continuous therapy for more than one year. Two fractures occurred (one of a metatarsal and one of a humerus) following minimal trauma. Growth failure was noted in four patients who were still receiving steroid therapy at the conclusion of the study period. All were in or below the third percentile for height and had received steroid therapy for 3Y4 years or more with continuous therapy comprising at least one-third of the total treatment time.
No complications of intermittent therapy were seen.
PROGNOSIS IN DECADE PRIOR TO STEROID THRAPY
Russell' has summarized the status of a group of 29 children with the nephrotic syndrome studied at this institution in the decade ending in 1948. At the end of the study period 3 (10%o) were in complete remission 10 months to 8 years after onset. Three (10%o) were clinically well with mild proteinuria 3 to 5.5 years after onset and 5 (17%o) were clinically well with marked proteinuria after 2 months to 4.5 years. Eight (28%o) still had the nephrotic syndrome 3 months to 3 years after onset, and 10 (35%o) had died from 2 weeks to 2 years after onset.
DISCUSSION
No child included in the series had known renal disease prior to the onset of the nephrotic syndrome. During the period of the study three patients were seen on whom a diagnosis of chronic nephritis had been made previously; they were excluded. The preponderance of males in this study has also been noted by others," although this has not been a consistent finding. The relatively few Negro and Puerto Rican children in this series corresponds to the proportion of these groups in this area.
It is of interest that the onset of the illness was associated with infection in 38 cases (54%o). Almost all of these were minor, nonbacterial upper respiratory infections for which an etiological role in the nephrotic syndrome can only be assumed (Table 1) . Such an inference appears justified, since similar disorders appear to have been responsible for all of the transient proteinurias as well as nearly one-third of the recurrences of the full-blown nephrotic syndrome. The incidence of familial renal disease other than the nephrotic syndrome is significantly higher than that reported by Barnett,' and the incidence Glucocorticoid therapy in nephrotic syndromeI GRYBOSKI, BRANDT of allergy is similar to his figure and thus higher than in the general population.
The 71 cases segregate into two groups on the basis of the relationship between the age at onset of the disorder and the condition at the end of the study period. In Figure 1 it will be noted that the 59 patients who developed the nephrotic syndrome while under six years of age were either well or else had not survived, while only one patient had a persistent proteinuria. The latter had initially attained complete remission but had developed diabetes in 1953. On the other hand, all 12 of those who developed the disorder after six years of age had survived, although an appreciable proportion (42%) had active nephrotic syndrome or persistent proteinuria. Only one manifested chronic glomerulonephritis clinically, while histological examination of biopsy specimens of kidney tissue in two others demonstrated a picture consistent with such a diagnosis. This dissociation between the severity of the histological and clinical picture in some patients has been noted by others."7"8 The older children appeared to follow a pattern of response to therapy resembling that of the adult."' This suggests that there may be either two or more basic disorders or an age specific variation in the manifestations of a single basic disorder; it is also possible that both factors may be involved. The uniformly fatal outcome in young infants is pertinent to these speculations. ' The four children who had siblings with the nephrotic syndrome all developed the disorder after the third year of life, responded to therapy within 3 weeks, and were in complete remission 9 months to 9 years later. This is contrary to the course of events in the "familial nephrosis" described by Vernier in which the manifestations frequently appear earlier in life and are more resistant to therapy.'
A relative paucity of serious infection was noted during the treatment period. Indeed, while there was initially some concern about bringing about antibiotic-resistant infection secondary to the prolonged administration of tetracyclines, no such problem developed. Several mild cases of oral moniliasis were noted, but these responded rapidly to specific antifungal therapy. Parents frequently commented that the children under treatment not only had fewer respiratory infections than previously, but also seemed to escape some of the family-wide epidemics.
A bacteriologically unconfirmed diagnosis of peritonitis was made in 3 patients, and infection contributed to 3 deaths. The bacteriological findings of the latter are described in Table 3 . This is in contrast to the occurrence of infection at this center during the decade prior to the availability of steroid therapy and the use of prophylactic antibiotics.1' During that period 28%o of patients with the nephrotic syndrome developed peritonitis, 30%o developed septicemia, and 29%o developed pneumonia one or more times. Pneumococcus was the most frequently identified organism. With the use of prophylactic antibiotics, infection by this organism has virtually disappeared. Infection brought about 40%o of the deaths in the pre-steroid decade at this institution and 30%o of the deaths in the present series. All patients in both groups who died from infection did so within 11 months of their initial visit to the hospital. Coliform bacilli were cultured firom all but one patient.
The high number of relapses which were associated with upper respiratory infections, most likely viral in origin, may to some extent be attributed to the relative lack of confinement and isolation precautions. It was felt that since the majority of patients became clinically well the advantages to both them and their families of leading a nearly normal life seemed to outweigh the possible consequences of increased exposure to infection.
Despite the frequent relapses, it was gratifying to note that most children who did so while on low dosage continuous therapy or on intermittent therapy, and all of those who did so after successful completion of therapy, experienced a complete remission following an additional course of full-dosage continuous glucocorticoid. Similar experiences have been described by others.`" This suggests that the nephrotic syndrome is a manifestation of some more fundamental process which, if not advanced to an irreversible stage, can be more or less corrected, so that the effects of repeated episodes are not cumulative.
Conversely, recurrences which appeared in children receiving high dosage continuous therapy carried a poor prognosis. The transient proteinurias associated with upper respiratory infections cleared spontaneously without alteration of therapy and did not appear to affect the over-all prognosis. Since these have been categorized only during the last three years of the study it is possible that prior to that time some children had been needlessly subjected to the resumption of full-dosage continuous therapy at the first reappearance of proteinuria.
The relationship between the duration of therapy and the length of time that the patients were free of proteinuria could not be evaluated because of the high recurrence rate.
In general a favorable outcome has been associated with a complete response to therapy within 3 weeks (Table 4 ). The maintenance of com-plete remission for the ensuing 12 months, or rapid response to therapy of exacerbations which occurred during that time have been associated with a benign long-term course. Although McCrory, et al.2' have noted a benign long-term course in patients who are in clinical remission 3 months after the initiation of therapy, this has not been the experience in the present study. The prospect for recovery was poor in those who did not respond to therapy or who required more than 35 weeks of treatment to bring about some degree of remission.
The length of time between the onset of the nephrotic syndrome and the beginning of hormone therapy did not appear to affect the results (Table  4) . Nor could a direct correlation be found between the length of time from onset to therapy and the mortality rate. This is contrary to the conclusions reached in the reports of Heymann,' Lange,' and Piel' in which the percentage of cures decreased and the percentage of deaths increased with the duration of the disorder prior to therapy.
It is of interest to attempt to correlate specific findings present before therapy with the condition of the patients at the conclusion of the study ( Table 2 ). The association of an appreciable degree of hematuria at the time of onset of the nephrotic syndrome with a poor prognosis has been frequently noted, both before6 and since' steroid therapy became available. An increase in mortality rate associated with other manifestations of nephritis (azotemia and hypertension) has been similarly noted previously.'3 In the present series, however, only the degree of edema and of hypoalbuminemia and the concurrent association of hypertension, azotemia and marked hematuria had a statistically significant effect on survival as determined by the chi square method (Table 2 ). Barnett's group discussed the poor correlation between the clinical picture at onset and the ultimate prognosis. ' Azotemia or hematuria alone were not considered contraindications to the use of glucocorticoid therapy, and the latter was initiated or maintained despite elevation of arterial pressure as high as 150/100 mm. Hg. When a greater rise occurred, the medication was decreased in dosage or discontinued.
The three patients who presented initially with azotemia, hematuria and hypertension were all treated with continuous therapy for a period of several months. Two began treatment with ACTH followed by prednisone, but the third did not have the initial course of ACTH. Their deterioration was a gradual phenomenon and did not appear to become accelerated by therapy.
While the glucocorticoid schedule in this series is comparable to that employed by others (Table 5) , none report the maintenance of therapy beyond 18 months after the urine protein test has become negative. Since other investigators have attained much the same results administering steroids for as little as 28 days, there may not have been any advantage in extending therapy beyond this time, particularly in those patients who have had complete remissions within three weeks of initiation of therapy and who have not had relapses. This question is an impossible one to resolve in an uncontrolled retrospective study such as this; yet it is important enough so that one would hope that properly controlled prospective series will be accumulated.
Most authorities would agree, however, that patients who have not shown a favorable early response would appear to benefit from a more prolonged course of therapy individualized according to the degree and persistence of their proteinuria. In support of this are the demonstrations by Galan and Maso' and Worthen, et al."8 of improvement in the morphological glomerular lesions during steroid therapy. One patient who had persistent proteinuria has attained complete remission since completion of the survey after five months of intensive continuous therapy. Although others8 " ' feel that there is no benefit in the prolongation of continuous therapy beyond one month in the presence of proteinuria, the low number of children with residual proteinuria in this series may imply an advantage to prolonging it to as long as six months, employing a daily dose of iup to 60 mg. of prednisone, followed by intermittent therapy for a maximum of one year. However, it is not possible to state with certainty whether the results so obtained in the relatively few cases who did not respond within the first three weeks (Table 4) The results obtained by prolonging glucocorticoid therapy to more than 3 years in patients who had responded within 3 weeks and who had not had early relapses did not appear to be any better than those obtained by other workers who administered steroids for one month. Properly controlled prospective studies are needed, however, in order to assess the significance of this finding. Further prolonging the therapy may benefit those who have not shown a favorable early response.
